You are here

AKT inhibitors

Roche Abandons AKT Prostate Cancer Asset

BioSpace

Thu, 02/2/23 - 10:52 am

clinical trials

castration-resistant prostate cancer

prostate cancer

Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers

Endpoints

Sun, 08/28/22 - 10:10 pm

Vaderis Therapeutics